These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9839501)

  • 1. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
    Shibuya Y; Okabayashi T; Oda K; Tanaka N
    Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript.
    Miwa T; Watanabe A; Yamada Y; Shino Y; Yamada T; Yamashita J; Matsuda M; Nakano H
    Cancer; 1996 Jan; 77(1):25-9. PubMed ID: 8630934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of CD44 variant isoforms in human primary colon carcinomas and metastasis].
    Shibuya Y; Okabayashi T; Oda K; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():169-73. PubMed ID: 8678563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
    Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
    Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 variants in colorectal carcinoma quantified by real-time reverse transcriptase-polymerase chain reaction.
    Ni HM; Leong AF; Cheong D; Hooi SC
    J Lab Clin Med; 2002 Jan; 139(1):59-65. PubMed ID: 11873246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo expression of CD44 variants in sporadic and hereditary gastric cancer.
    da Cunha CB; Oliveira C; Wen X; Gomes B; Sousa S; Suriano G; Grellier M; Huntsman DG; Carneiro F; Granja PL; Seruca R
    Lab Invest; 2010 Nov; 90(11):1604-14. PubMed ID: 20856229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer.
    Yamao T; Matsumura Y; Shimada Y; Moriya Y; Sugihara K; Akasu T; Fujita S; Kakizoe T
    Gastroenterology; 1998 Jun; 114(6):1196-205. PubMed ID: 9609756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
    Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
    BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
    Yokoyama S; Yamaue H
    Arch Surg; 2002 Sep; 137(9):1069-73. PubMed ID: 12215164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer.
    Yamamichi K; Uehara Y; Kitamura N; Nakane Y; Hioki K
    Int J Cancer; 1998 Jun; 79(3):256-62. PubMed ID: 9645347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
    Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
    J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
    Gorham H; Sugino T; Woodman AC; Tarin D
    J Clin Pathol; 1996 Jun; 49(6):482-8. PubMed ID: 8763263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
    Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
    Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
    Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
    Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 splice variants as prognostic markers in colorectal cancer.
    Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
    Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
    Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
    Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.